Category: Disclosures

[Disclosure] SK Square (402340) – Report on Reason for Holding General Shareholders’ Meeting on Concentrated Date / 2025-02-25

February 25, 2025July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square reported that it will inevitably hold its 2025 annual general shareholders’ meeting on March 27, a designated concentrated date, due to external audit schedules and ensuring sufficient time for shareholder review. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – Submission of Audit Report / 2025-02-25

February 25, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed the submission of its Audit Report for FY2024, receiving an ‘Unqualified’ audit opinion from Samil PricewaterhouseCoopers for both consolidated and separate financial statements. Consolidated revenue reached KRW 4.547T, with an operating profit of KRW 1.320T. 📊 [Key Disclosure Details & Financial Figures]…

Disclosures, Bio & Healthcare

[Disclosure] KEPCO (015760 / KEP) – Pre-announcement of Financial Results / 2025-02-25

February 25, 2025August 13, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO has announced in advance that it plans to disclose its FY2024 consolidated financial results on February 28, 2025. 📊 [Key Disclosure Contents & Major Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Timely Filing and Confirmed Figures Following External…

Disclosures, Energy

[Disclosure] Celltrion (068270) – Change in Revenue or Profit/Loss Structure Exceeding 15% / 2025-02-25

February 25, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion achieved record-high annual consolidated revenue of KRW 3.56T in 2024 (up 63.45% YoY), driven by expanded global prescriptions of existing products and rapid growth of new products. However, due to higher cost-of-goods-sold from legacy Celltrion Healthcare inventory, amortization of intangible assets (such as sales rights)…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Provisional Separate Financial Results / 2025-02-25

February 25, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion reported Q4 2024 separate revenue of KRW 1.06T (up 235.96% YoY) and operating profit of KRW 407.5B, with full-year 2024 cumulative separate revenue reaching KRW 3.71T, an increase of 97.99% YoY. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Provisional Consolidated Financial Results / 2025-02-25

February 25, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion reported Q4 2024 consolidated revenue of KRW 1.06T (up 178.01% YoY) and operating profit of KRW 196.4B, with full-year 2024 cumulative revenue reaching KRW 3.56T, an increase of 63.45% YoY. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Resolution on Convening Annual General Meeting of Shareholders / 2025-02-25

February 25, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion decided to convene its 34th Annual General Meeting of Shareholders on March 25, 2025, to vote on agenda items including financial statement approval, capital reserve reduction, and the re-election of Chairman Seo Jung-jin as a director. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s…

Disclosures, Bio & Healthcare

[Disclosure] KEPCO (015760 / KEP) – Investor Relations (IR) Announcement / 2025-02-25

February 25, 2025August 13, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO will hold an Investor Relations (IR) conference call on February 28, 2025, to announce its FY2024 earnings results, with IR materials to be published on March 6. 📊 [Key Disclosure Contents & Major Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Disclosures, Energy

[Disclosure] LEENO Industrial (058470) – Resolution on Convocation of Annual General Meeting of Shareholders / 2025-02-25

February 25, 2025August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary LEENO Industrial resolved to convene its 29th Annual General Meeting of Shareholders on March 26, 2025, with agenda items including a cash dividend of KRW 3,000 per common share and Articles of Incorporation amendments for a stock split. 📊 [Key Disclosure Details & Financial Figures] 📝…

Semiconductors, Disclosures

[Disclosure] Hanwha Aerospace (012450) – Decision on General Meeting of Shareholders / 2025-02-24

February 24, 2025August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace has disclosed its board resolution to convene the 48th Annual General Meeting of Shareholders on March 25, 2025, to vote on key agendas including financial statement approval (with a KRW 3,500 cash dividend), director appointments, and articles amendment. 📊 [Key Disclosure Contents & Major…

Disclosures, Defense